“…Biological markers of inflammatory pathways and stress responses such as proinflammatory cytokines, adrenaline, cortisol, and complement activity are reduced. [36][37][38] There is convincing evidence that EVAR is associated with reduced cardiac, respiratory, and renal complications, reduced need for blood transfusion and analgesia, shorter duration of surgery and postoperative hospital stay, lower need for intensive care, a faster return to normal function, and lower infection rates. 16 32 39-43 Until earlier this year, in the absence of evidence from large national randomised controlled trials, information on the efficacy of EVAR relied upon observational case series and data from large voluntary registries, such as the UK Registry for Endovascular Treatment of Aneurysms (RETA), and in particular, the European Collaborators on Stent Graft Techniques for Abdominal Aortic Aneurysm Repair (EUROSTAR) Registry.…”